<code id='F8A73F3013'></code><style id='F8A73F3013'></style>
    • <acronym id='F8A73F3013'></acronym>
      <center id='F8A73F3013'><center id='F8A73F3013'><tfoot id='F8A73F3013'></tfoot></center><abbr id='F8A73F3013'><dir id='F8A73F3013'><tfoot id='F8A73F3013'></tfoot><noframes id='F8A73F3013'>

    • <optgroup id='F8A73F3013'><strike id='F8A73F3013'><sup id='F8A73F3013'></sup></strike><code id='F8A73F3013'></code></optgroup>
        1. <b id='F8A73F3013'><label id='F8A73F3013'><select id='F8A73F3013'><dt id='F8A73F3013'><span id='F8A73F3013'></span></dt></select></label></b><u id='F8A73F3013'></u>
          <i id='F8A73F3013'><strike id='F8A73F3013'><tt id='F8A73F3013'><pre id='F8A73F3013'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          explore

          author:Wikipedia    - browse:2558
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          entertainment